CoChat

The COX‐2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain

Open access
Goncalves, Maria Beatriz, Williams, Emma‐Jane, Yip, Ping, Yáñez‐Muñoz, Rafael J, Williams, Gareth, Doherty, Patrick · 2010 · British Journal of Pharmacology
Cited by 64

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Background and purpose: In adults, neurogenesis persists in the hippocampus and the subventricular zone (SVZ), and this is important for learning and memory. Inhibitors of COX‐2 suppress ischaemia‐induced neurogenesis in the hippocampus. Here, we have determined the effects of COX‐2 inhibitors on neurogenesis throughout the normal adult mouse brain. Experimental approach: Young adult mice were treated with COX‐2 inhibitors, and the proliferation of neural progenitor cells was measured in the SVZ and hippocampus. In addition, the local uptake of lentiviral vectors in the rostral migratory stream enabled the formation of new neurons in the olfactory bulb (OB) to be assessed. Key results: The COX‐2 inhibitor meloxicam suppressed progenitor cell proliferation in the SVZ and hippocampus. A significant decrease in the appearance of new neurons in the OB was also observed. Similar effects on progenitor proliferation in the SVZ were seen with nimesulide. The absence of COX‐2 expression in the proliferating progenitors in vivo, and the lack of effect of the COX‐2 inhibitors on the growth rate of a cultured progenitor cell line, suggest that the effect is indirect. The specific expression of COX‐2 in resting microglia that closely associate with the proliferating progenitor cells provides for a possible site of action. Conclusions and implications: Treatment with a COX‐2 inhibitor results in a substantial inhibition of adult neurogenesis. Studies on human tissues are warranted in order to determine if this effect extends to humans, and whether inhibition of neurogenesis should be considered as an adverse effect of these drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2009.00618.x

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 64

Metadata

Authors
Goncalves, M. B., Williams, E., Yip, P., Yáñez‐Muñoz, R. J., Williams, G., & Doherty, P.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2010-03
Volume
159
Issue
5
Pages
1118-1125
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1487241194
Cited by
64
References
11
FWCI
1.95
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The COX‐2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00618.x
The paper
Goncalves, M. B., Williams, E., Yip, P., Yáñez‐Muñoz, R. J., Williams, G., & Doherty, P. (2010). The COX‐2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brain. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00618.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.